Back to CERS Stock Lookup

Cerus Corp (CERS) – Press Releases

Jan 28, 2015 08:00 AM Ash Stevens to Manufacture Amotosalen Active Pharmaceutical Ingredient for Cerus' INTERCEPT Blood System
Jan 7, 2015 08:00 AM Cerus Prices $70.0 Million Public Offering of Common Stock
Jan 5, 2015 04:01 PM Cerus Announces Proposed Public Offering of Common Stock
Jan 5, 2015 07:45 AM Cerus Reports EU Phase 3 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint
Dec 22, 2014 08:30 AM Cerus Reports US Phase 2 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint
Dec 18, 2014 07:20 PM FDA Approves INTERCEPT Blood System for Platelets
Dec 16, 2014 05:31 PM FDA Approves INTERCEPT Blood System for Plasma
Nov 21, 2014 08:30 AM FDA Accepts IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent Plasma
Nov 4, 2014 04:01 PM Cerus Corporation Reports Third Quarter 2014 Results

Back to CERS Stock Lookup